Found: 5
Select item for more details and to access through your institution.
Treatment of Recurrent Epidermolysis Bullosa Acquisita With Tofacitinib.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 3, p. 342, doi. 10.1001/jamadermatol.2022.6250
- By:
- Publication type:
- Article
Predictors of treatment failure after top‐hat procedure in squamous intraepithelial lesion.
- Published in:
- Journal of Obstetrics & Gynaecology Research, 2021, v. 47, n. 2, p. 661, doi. 10.1111/jog.14578
- By:
- Publication type:
- Article
Tofacitinib in recalcitrant bullous pemphigoid: a report of seven cases.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 3, p. 432, doi. 10.1093/bjd/ljac078
- By:
- Publication type:
- Article
Evaluation of clinical factors and outcome of systemic glucocorticoid therapy discontinuation in patients with pemphigus achieving complete remission.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 10, p. 1347, doi. 10.1111/1346-8138.16838
- By:
- Publication type:
- Article
Ruxolitinib, a JAK1/2 Inhibitor as Treatment for Paraneoplastic Pemphigus: A Case Report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study